EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Right Superior Orbitofrontal Gray Matter Volume Reduction Mediates Executive Dysfunction in Schizophrenia Patients With Comorbid Metabolic Syndrome

Hangyu Li iD, Xinyan Wu iD, Xinyue Chen iD, Ying Li iD, Shiji Peng iD, Rui Yu iD, Nian Liu iD

Alpha Psychiatry · 16.10.2026 · 27 (5)

DOI: 10.31083/ap52539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alpha Psychiatry, online erschienen am 16.10.2026. Verfasst von Hangyu Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Affiliated Hospital of North Sichuan Medical College, 637000 Nanchong, Sichuan, China. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Youth innovation project of Sichuan Medical Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with schizophrenia (SCZ) are at a markedly increased risk of developing metabolic syndrome (MetS), which substantially reduces life expectancy and adversely affects treatment adherence. Although cognitive impairment is a core feature of SCZ, the neurobiological mechanisms linking comorbid MetS to cognitive dysfunction remain complex and incompletely understood. Previous studies have primarily focused on the effects of abnormal brain function and white matter abnormalities on cognition, whereas the contribution of gray matter volume (GMV) alterations in the context of comorbid MetS has received comparatively less attention. Accordingly, this study examined GMV alterations in patients with SCZ and comorbid MetS and evaluated whether these alterations mediate the association between MetS and cognitive impairment.

Methods

Sixty clinically stable patients with SCZ receiving risperidone or clozapine were recruited, including 28 meeting the diagnostic criteria for MetS (SCZ-MetS) and 32 without MetS (SCZ-nMetS), together with 31 demographically matched healthy controls (HCs). High-resolution structural magnetic resonance imaging (MRI) scans were analyzed using voxel-based morphometry (VBM) to quantify GMV. Mediation analyses were performed to determine whether GMV alterations mediated the association between MetS and cognitive function.

Results

Compared with the HC group, both the SCZ-nMetS and SCZ-MetS groups exhibited widespread GMV reductions involving the cingulate cortex, left temporal lobe, frontal regions, and insula. Compared with the SCZ-nMetS group, the SCZ-MetS group showed significantly reduced GMV in the right superior orbitofrontal gyrus, as well as in the left amygdala, left insula, and temporal lobe (p < 0.05). Mediation analysis indicated that reduced GMV in the right superior orbitofrontal gyrus significantly mediated the association between MetS and deficits in executive function (p < 0.05).

Conclusions

MetS-related executive dysfunction may be partly associated with reduced GMV in the right superior orbitofrontal gyrus, suggesting a potential mediating role of this brain region.

Schlagwörter

Stichwörter der Autor:innen

cognitive functionexecutive functiongray matter volumemediation analysismetabolic syndromeschizophrenia

Autor:innen und Institutionen

  • Department of Radiology, Affiliated Hospital of North Sichuan Medical College, 637000 Nanchong, Sichuan, China.
  • Nuclear Medicine and Radiation Safety Key Laboratory of Sichuan Province, North Sichuan Medical College, 637000 Nanchong, Sichuan, China.

ORCID-Profile: Hangyu Li, Xinyan Wu, Xinyue Chen, Ying Li, Shiji Peng, Rui Yu, Nian Liu

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Youth innovation project of Sichuan Medical Association
  • Research Innovation Team of North Sichuan Medical College

Zitieren

APA

Li, H., Wu, X., Chen, X., Li, Y., Peng, S., Yu, R., & Liu, N. (2026). Right Superior Orbitofrontal Gray Matter Volume Reduction Mediates Executive Dysfunction in Schizophrenia Patients With Comorbid Metabolic Syndrome. Alpha Psychiatry, 27(5). https://doi.org/10.31083/ap52539

Vancouver

Li H, Wu X, Chen X, Li Y, Peng S, Yu R, et al. Right Superior Orbitofrontal Gray Matter Volume Reduction Mediates Executive Dysfunction in Schizophrenia Patients With Comorbid Metabolic Syndrome. Alpha Psychiatry. 2026;27(5). doi:10.31083/ap52539

BibTeX
@article{Li2026,
  author = {Li, Hangyu and Wu, Xinyan and Chen, Xinyue and Li, Ying and Peng, Shiji and Yu, Rui and Liu, Nian},
  title = {Right Superior Orbitofrontal Gray Matter Volume Reduction Mediates Executive Dysfunction in Schizophrenia Patients With Comorbid Metabolic Syndrome},
  journal = {Alpha Psychiatry},
  year = {2026},
  volume = {27},
  number = {5},
  doi = {10.31083/ap52539}
}
Kostenlos starten →